Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.
本发明涉及化合物(I)的制备方法,其中化合物(I)可以是其药学上可接受的N-
氧化物、盐、
水合物、溶剂合物、复合物、
生物等价物、代谢物或者前药。这些化合物可用于治疗由Clostridium difficile引起的感染和疾病。